The value of prophylactic cranial irradiation in limited-stage small cell lung cancer: should it always be recommended?

PURPOSE: Prophylactic cranial irradiation (PCI) is a standard treatment for limited-stage small cell lung cancer (LS-SCLC) showing a response to initial treatment, but many patients do not receive PCI due to comorbidities or refusal. This study aims to define the patient group for whom PCI can be om...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Minji, Song, Si Yeol, Jo, Ji Hwan, Park, Geumju, Park, Jae Won, Kim, Su Ssan, Choi, Eun Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790796/
https://www.ncbi.nlm.nih.gov/pubmed/31591863
http://dx.doi.org/10.3857/roj.2019.00318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790796/
https://www.ncbi.nlm.nih.gov/pubmed/31591863
http://dx.doi.org/10.3857/roj.2019.00318

Ejemplares similares